These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 20800984)

  • 1. MR findings of focal eosinophilic liver disease using gadoxetic acid.
    Lee J; Park CM; Kim KA; Lee CH; Choi JW
    Magn Reson Imaging; 2010 Nov; 28(9):1327-34. PubMed ID: 20800984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Focal eosinophilic infiltration of the liver: gadoxetic acid-enhanced magnetic resonance imaging and diffusion-weighted imaging.
    Ahn SJ; Choi JY; Kim KA; Kim MJ; Baek SE; Kim JH; Song HT
    J Comput Assist Tomogr; 2011; 35(1):81-5. PubMed ID: 21160434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Can MR fluoroscopic triggering technique and slow rate injection provide appropriate arterial phase images with reducing artifacts on gadoxetic acid-DTPA (Gd-EOB-DTPA)-enhanced hepatic MR imaging?
    Haradome H; Grazioli L; Tsunoo M; Tinti R; Frittoli B; Gambarini S; Morone M; Motosugi U; Colagrande S
    J Magn Reson Imaging; 2010 Aug; 32(2):334-40. PubMed ID: 20677259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Double-dose gadoxetic Acid-enhanced magnetic resonance imaging in patients with chronic liver disease.
    Motosugi U; Ichikawa T; Sano K; Sou H; Onohara K; Muhi A; Kitamura T; Amemiya F; Enomoto N; Matsuda M; Asakawa M; Fujii H; Araki T
    Invest Radiol; 2011 Feb; 46(2):141-5. PubMed ID: 21139506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A case of Budd-Chiari syndrome: Gd-EOB-DTPA-enhanced MR findings.
    Kitajima K; Yoshikawa T; Seo Y; Ohno Y; Yano Y; Miki A; Kanda T; Kanata N; Azuma T; Sugimura K
    Magn Reson Imaging; 2011 May; 29(4):579-83. PubMed ID: 21216550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison between areas with Gd-EOB-DTPA uptake and without in hepatocellular carcinomas on Gd-EOB-DTPA-enhanced hepatobiliary-phase MR imaging: pathological correlation.
    Lee S; Kim SH; Park CK; Kim YS; Lee WJ; Lim HK
    J Magn Reson Imaging; 2010 Sep; 32(3):719-25. PubMed ID: 20815073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of cirrhotic nodules with gadoxetic acid-enhanced magnetic resonance imaging: the efficacy of hepatocyte-phase imaging.
    Chou CT; Chen YL; Su WW; Wu HK; Chen RC
    J Magn Reson Imaging; 2010 Oct; 32(4):895-902. PubMed ID: 20882620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MR imaging of the biliary tract with Gd-EOB-DTPA: effect of liver function on signal intensity.
    Takao H; Akai H; Tajima T; Kiryu S; Watanabe Y; Imamura H; Akahane M; Yoshioka N; Kokudo N; Ohtomo K
    Eur J Radiol; 2011 Feb; 77(2):325-9. PubMed ID: 19726150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of hyperintense nodules on precontrast T1-weighted MRI: utility of gadoxetic acid-enhanced hepatocyte-phase imaging.
    Chou CT; Chen YL; Wu HK; Chen RC
    J Magn Reson Imaging; 2011 Mar; 33(3):625-32. PubMed ID: 21563246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MRI findings of focal eosinophilic liver diseases.
    Kim YK; Kim CS; Moon WS; Cho BH; Lee SY; Lee JM
    AJR Am J Roentgenol; 2005 May; 184(5):1541-8. PubMed ID: 15855113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contrast-enhanced magnetic resonance cholangiography with Gd-BOPTA and Gd-EOB-DTPA in healthy subjects.
    Dahlström N; Persson A; Albiin N; Smedby O; Brismar TB
    Acta Radiol; 2007 May; 48(4):362-8. PubMed ID: 17453513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Focal nodular hyperplasia: central scar enhancement pattern using Gadoxetate Disodium.
    Karam AR; Shankar S; Surapaneni P; Kim YH; Hussain S
    J Magn Reson Imaging; 2010 Aug; 32(2):341-4. PubMed ID: 20677260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liver parenchymal enhancement of hepatocyte-phase images in Gd-EOB-DTPA-enhanced MR imaging: which biological markers of the liver function affect the enhancement?
    Motosugi U; Ichikawa T; Sou H; Sano K; Tominaga L; Kitamura T; Araki T
    J Magn Reson Imaging; 2009 Nov; 30(5):1042-6. PubMed ID: 19856436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved detection of focal liver lesions at MR imaging: multicenter comparison of gadoxetic acid-enhanced MR images with intraoperative findings.
    Huppertz A; Balzer T; Blakeborough A; Breuer J; Giovagnoni A; Heinz-Peer G; Laniado M; Manfredi RM; Mathieu DG; Mueller D; Reimer P; Robinson PJ; Strotzer M; Taupitz M; Vogl TJ;
    Radiology; 2004 Jan; 230(1):266-75. PubMed ID: 14695400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gadoxetic acid disodium-enhanced hepatocyte phase MRI: can increasing the flip angle improve focal liver lesion detection?
    Haradome H; Grazioli L; Al manea K; Tsunoo M; Motosugi U; Kwee TC; Takaraha T
    J Magn Reson Imaging; 2012 Jan; 35(1):132-9. PubMed ID: 21960465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dynamic contrast-enhanced magnetic resonance imaging of abdominal solid organ and major vessel: comparison of enhancement effect between Gd-EOB-DTPA and Gd-DTPA.
    Tamada T; Ito K; Sone T; Yamamoto A; Yoshida K; Kakuba K; Tanimoto D; Higashi H; Yamashita T
    J Magn Reson Imaging; 2009 Mar; 29(3):636-40. PubMed ID: 19243060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gd-EOB-DTPA-enhanced magnetic resonance imaging findings of nondiffuse fatty change of the liver.
    Yamamoto A; Tamada T; Sone T; Higashi H; Yamashita T; Ito K
    J Comput Assist Tomogr; 2010; 34(6):868-73. PubMed ID: 21084902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gadoxetate disodium-enhanced MRI of the liver: part 1, protocol optimization and lesion appearance in the noncirrhotic liver.
    Ringe KI; Husarik DB; Sirlin CB; Merkle EM
    AJR Am J Roentgenol; 2010 Jul; 195(1):13-28. PubMed ID: 20566794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gadolinium-ethoxybenzyl-DTPA, a new liver-specific magnetic resonance contrast agent. Kinetic and enhancement patterns in normal and cholestatic rats.
    Clément O; Mühler A; Vexler V; Berthezène Y; Brasch RC
    Invest Radiol; 1992 Aug; 27(8):612-9. PubMed ID: 1428739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T2-weighted magnetic resonance imaging of the liver: evaluation of the effect in signal intensity after Gd-EOB-DTPA enhancement.
    Tamada T; Ito K; Yoshida K; Sone T; Murakami K; Kanki A; Watanabe S; Higashi H; Yamashita T
    J Comput Assist Tomogr; 2010; 34(2):182-6. PubMed ID: 20351500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.